Timothy P Oneill
Affiliation: The Procter and Gamble Company
- Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animalsRichard T Hinkle
Research Division, Procter and Gamble Company, Mason, OH, USA
BMC Musculoskelet Disord 12:15. 2011..Corticotrophin releasing factor 2 receptor (CRF2R) agonists have been shown to maintain skeletal muscle mass and force production in a variety of acute conditions that lead to skeletal muscle wasting...